Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)

China flag China · Delayed Price · Currency is CNY
14.15
-0.03 (-0.21%)
May 20, 2026, 11:54 AM CST
Market Cap11.54B -3.6%
Revenue (ttm)4.04B -6.6%
Net Income759.89M -1.2%
EPS0.92 +2.1%
Shares Out813.76M
PE Ratio15.42
Forward PE13.50
Dividend0.35 (2.47%)
Ex-Dividend DateMay 29, 2025
Volume4,421,535
Average Volume10,712,798
Open14.22
Previous Close14.18
Day's Range14.01 - 14.35
52-Week Range12.79 - 22.62
Beta-0.07
RSI35.93
Earnings DateApr 24, 2026

About SHE:002020

Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products in China. The company offers APIs, antihypertensive products, antibiotics, quinolones, gastrointestinal promotions, antidiabetics, antipileptics, antihistamines, H+ pump depressants, antihyper cholesterolemia products, histamine H2 receptor blokades, antihyper cholesterolemirs, antidepressants, cephalosporin products, and biopharma products. It also provides diagnostic medical displays, surgical medical displays, clinical medical displ... [Read more]

Sector Healthcare
Founded 1990
Employees 3,869
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002020
Full Company Profile

Financial Performance

In 2024, SHE:002020's revenue was 4.16 billion, an increase of 3.99% compared to the previous year's 4.00 billion. Earnings were 711.96 million, an increase of 15.04%.

Financial Statements